Pediatric Rheumatology Curriculum for the Pediatrics Resident: A Case-Based Approach to Learning

Miriah Gillispie1, Eyal Muscal2,3, Jennifer Rama4

  • 1Fellow, Department of Pediatrics, Section of Immunology, Allergy, and Rheumatology, Baylor College of Medicine at Texas Children's Hospital.

Insights

A new pediatric rheumatology curriculum improved resident confidence in diagnosing and managing autoimmune diseases in children. This training addresses a critical gap, enhancing skills for early detection and referral of pediatric rheumatologic conditions.

Area of Science:

  • Pediatric Rheumatology
  • Medical Education
  • Autoimmune Diseases

Background:

  • Pediatric rheumatologic diseases are common yet underrecognized, affecting approximately 1 in 250 children with juvenile arthritis.
  • A shortage of pediatric rheumatologists nationwide exacerbates diagnostic and treatment challenges.
  • Gaps exist in resident training regarding the workup, examination, and management of pediatric autoimmune conditions.

Purpose of the Study:

  • To develop and evaluate a case-based curriculum to enhance pediatric residents' skills in rheumatologic disease management.
  • To improve resident comfort and competence in diagnosing and referring pediatric autoimmune diseases.

Main Methods:

  • A six-step curriculum development method was employed, focusing on workup, musculoskeletal exam, lab interpretation, and referral.
  • The curriculum consisted of case discussions and an observed musculoskeletal exam session for pediatric and internal medicine-pediatric residents.

Main Results:

  • The curriculum successfully increased resident comfort in identifying symptoms, physical exam findings, and appropriate laboratory studies for autoimmune diseases.
  • Trainees reported improved confidence in managing and referring pediatric rheumatologic cases.
  • Weekly sessions in 2017 reached 34 trainees, with survey results indicating significant learning gains.

Conclusions:

  • The case-based curriculum effectively addresses a critical gap in pediatric training for rheumatologic diseases.
  • Enhanced exposure to common autoimmune conditions and improved physical examination skills were key outcomes.
  • This program better prepares residents to manage children with potential rheumatologic conditions.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
225
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
285
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
213
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
272
Noncompartmental Analysis: Mean Residence Time01:05

Noncompartmental Analysis: Mean Residence Time

According to statistical moment theory, mean residence time (MRT) is an important measure in pharmacokinetics. MRT can be defined as the expected mean of a probability density function distribution. It provides valuable insights into drug disposition in the body.
After the administration of a drug through intravenous bolus injection, the drug molecules are distributed throughout the body and remain there for varying periods. The MRT represents the average time these drug molecules stay in the...
598
Avoidance Learning and Learned Helplessness01:14

Avoidance Learning and Learned Helplessness

Avoidance learning and learned helplessness are critical concepts in understanding behavioral responses to negative stimuli.
Avoidance learning occurs when an organism learns that a specific behavior can prevent an unpleasant outcome. For example, a student who receives a bad grade may start studying harder to avoid future poor grades. This behavior persists even when the negative outcome is no longer present. Avoidance learning is powerful because it maintains behavior in the absence of the...
2.6K